These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6816110)

  • 21. Heterogeneity and reduction in pulmonary clearance of mucoid Pseudomonas aeruginosa.
    Govan JR; Fyfe JA; Baker NR
    Rev Infect Dis; 1983; 5 Suppl 5():S874-9. PubMed ID: 6419313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis.
    Pedersen SS
    APMIS Suppl; 1992; 28():1-79. PubMed ID: 1449848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Auxotrophy of Pseudomonas aeruginosa in cystic fibrosis.
    Taylor RF; Hodson ME; Pitt TL
    FEMS Microbiol Lett; 1992 May; 71(3):243-6. PubMed ID: 1624122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration.
    Baltimore RS; Christie CD; Smith GJ
    Am Rev Respir Dis; 1989 Dec; 140(6):1650-61. PubMed ID: 2513765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiological analysis of sequential Pseudomonas aeruginosa isolates from chronic bronchiectasis patients without cystic fibrosis.
    Pujana I; Gallego L; Martín G; López F; Canduela J; Cisterna R
    J Clin Microbiol; 1999 Jun; 37(6):2071-3. PubMed ID: 10325384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucoid Pseudomonas aeruginosa in patients with chronic illnesses.
    Doggett RG; Harrison GM; Carter RE
    Lancet; 1971 Jan; 1(7692):236-7. PubMed ID: 4099895
    [No Abstract]   [Full Text] [Related]  

  • 27. Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis.
    Bienvenu T; Sermet-Gaudelus I; Burgel PR; Hubert D; Crestani B; Bassinet L; Dusser D; Fajac I
    Am J Respir Crit Care Med; 2010 May; 181(10):1078-84. PubMed ID: 20167849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis.
    Davies G; Wells AU; Doffman S; Watanabe S; Wilson R
    Eur Respir J; 2006 Nov; 28(5):974-9. PubMed ID: 16899482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transfer of a chromosomal locus responsible for mucoid colony morphology in Pseudomonas aeruginosa isolated from cystic fibrosis patients to P. aeruginosa PAO.
    MacGeorge J; Korolik V; Morgan AF; Asche V; Holloway BW
    J Med Microbiol; 1986 Jun; 21(4):331-6. PubMed ID: 3088280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Molecular typification of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis].
    Iglesias NG; Marengo JM; Rentería F; Gatti B; Segal E; Semorile L
    Rev Argent Microbiol; 2008; 40(1):3-8. PubMed ID: 18669045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The presence of mucoid pseudomonas is not pathognomonic for cystic fibrosis.
    Hart M; Borowitz D
    Clin Pediatr (Phila); 2004 Apr; 43(3):279-81. PubMed ID: 15094953
    [No Abstract]   [Full Text] [Related]  

  • 32. Molecular identification and genotyping of Pseudomonas aeruginosa isolated from cystic fibrosis and non-cystic fibrosis patients with bronchiectasis.
    Eusebio N; Amorim AA; Gamboa F; Araujo R
    Pathog Dis; 2015 Mar; 73(2):1-7. PubMed ID: 25722487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis.
    Henry RL; Mellis CM; Petrovic L
    Pediatr Pulmonol; 1992 Mar; 12(3):158-61. PubMed ID: 1641272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR; Pressler T; Høiby N
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis.
    Pier GB; Saunders JM; Ames P; Edwards MS; Auerbach H; Goldfarb J; Speert DP; Hurwitch S
    N Engl J Med; 1987 Sep; 317(13):793-8. PubMed ID: 2957591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can mucoid Pseudomonas aeruginosa be eradicated in children with cystic fibrosis?
    McPherson H; Rosenthal M; Bush A
    Pediatr Pulmonol; 2010 Jun; 45(6):566-8. PubMed ID: 20503281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different mutations in mucA gene of Pseudomonas aeruginosa mucoid strains in cystic fibrosis patients and their effect on algU gene expression.
    Pulcrano G; Iula DV; Raia V; Rossano F; Catania MR
    New Microbiol; 2012 Jul; 35(3):295-305. PubMed ID: 22842599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fecal isolation of Pseudomonas aeruginosa from patients with cystic fibrosis.
    Agnarsson U; Glass S; Govan JR
    J Clin Microbiol; 1989 Jan; 27(1):96-8. PubMed ID: 2492306
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Wang H; Ji XB; Mao B; Li CW; Lu HW; Xu JF
    BMJ Open; 2018 Mar; 8(3):e014613. PubMed ID: 29540404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of airway infection by Pseudomonas aeruginosa: a computed tomographic study.
    Miszkiel KA; Wells AU; Rubens MB; Cole PJ; Hansell DM
    Thorax; 1997 Mar; 52(3):260-4. PubMed ID: 9093343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.